Latest filing published 04 Mar 2022 for Pacific Biosciences of California, INC..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Peter Fromen: trading record in brief
Peter Fromen (senior executive) discloses dealings in Pacific Biosciences of California, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 8 January 2021 to 2 March 2022.
On the market, this insider has only sold: 1 sale, €249k in total. The rest of the record consists of 2 share grants. In 2022 alone, the filings show no purchases and 1 sale.
On 4 March 2022 came the latest disclosure, a share grant in Pacific Biosciences of California, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Peter Fromen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares0Common StockSEC:0001299130-22-000037:0
- 19,720 shares@ US$14.30100.0% of flowCommon StockSEC:0001299130-22-000010:0
2 of 2 declarations
